Moderna Asks FDA to Authorize Variant-Specific COVID Vaccine
June 22, 2022 – Moderna released study results today showing its new Omicron-specific booster increased antibodies against the coronavirus by a factor of 5, even against some of the newer and more worrisome variants. The company also today asked the FDA to authorize the use of the vaccine. The company said shipments of this vaccine … Read more